logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table GPS-16. Last month prevalence of drug use among the age group of 15 to 24 years old in nationwide surveys among the general population

Country Geographical areaYearRef.Age range (15-24)Sample size (15-24)Cannabis (%)Cocaine (%) (1)Amphet-amines (%) (2)Ecstasy (%) (3)LSD (%)
Belgium
Vlaanderen (Brussels excluded)1994(1)
French Community1996-97(2)18-243.1
French Community1998-99(3)18-249.2
French Community2000(4)18-2414.5
National2001(5)15-2411528.00.8
National2004(6)15-246.7
Bulgaria
National2005(1)18-241733.81.11.12.71.1
Czech Republic
National2002(1)18-24389
National2004(2)18-2458615.40.20.73.60.3
Denmark
National1990(1)
National1994(2)
National2000(3)16-2417547.70.81.50.70.3
National2005(4)16-2414348.20.81.40.50.0
Germany
East Germany1990(1)
Western Germany1990(2)
Old and New Länder1995(3)18-249.91.41.12.8
Old and New Länder1997(4)18-248.40.50.71.2
National2000(5)18-2496312.60.81.31.50.5
National2003(6)18-24189111.90.71.50.60.2
Estonia
National1998(1)18-242.01.0
National2003(2)15-243296.10.01.21.50.0
Ireland
National1998(1)
National1998(2)18-2415.3
National2000(3)
National2002-03(4)15-245.60.90.60.80.0
Greece
Athens1993(1)
National (except Aegean and Ionian Islands)1998(2)15-2413735.20.30.10.3
National (except Aegean and Ionian Islands)2004(3)15-241 7851.20.10.10.10.0
Spain
National1995(1)
National1997(2)15-249.11.50.70.7
National1999(3)15-2410.41.80.60.9
National2001(4)15-243 36814.22.41.21.9
National2003(5)15-24232715.02.00.71.0
National2005-06(6)15-24818818.63.11.01.5
France
National1992(1)
Metropolitan France1995(2)18-24
National1999(3)15-24
National2000(4)15-2413.80.30.20.30.3
Metropolitan France2002(5)15-24345
National2005(6)15-24466212.70.40.10.30.1
Italy
National2001(1)15-249.21.20.00.10.0
National2003(2)15-24211211.11.50.20.20.4
National2005(3)15-24900610.71.30.20.40.4
Cyprus
National2006(1)15-249692.00.40.40.80.6
Latvia
National2003(1)15-245.10.10.90.71.0
Lithuania
National2004(1)15-249232.00.30.30.70.1
Luxembourg
National1998(1)15-247.00.50.00.0
Hungary
National2001(1)15-243084.30.00.90.60.3
National2003(2)18-249434.80.61.31.30.4
Malta
National2001(1)18-24287
Netherlands
National1997-98(1)15-247.30.50.50.9
National2001(2)15-247.3
National2005(3)15-245.3
Austria
National2004(1)15-249597.60.50.81.00.1
Poland
National2002(1)16-244.30.30.70.80.2
Portugal
National2001(1)15-2430995.50.50.10.60.1
Romania
National2004(1)15-24
Slovakia
National2002(1)18-245.00.00.30.0
National2004(2)15-243073.90.00.01.0
Finland
National1992(1)
National1996(2)
National1998(3)
National2000(4)15-241.60.4
National2002(5)15-246143.70.11.00.40.0
National2004(6)15-244946.20.00.91.00.3
Sweden
National1994(1)16-24146
National1996(2)16-24228
National1998(3)16-242440.40.00.00.0
National2000(4)16-240.30.00.00.00.0
National2004(5)16-2411712.6
National2005(6)16-2445022.9
National2006(7)16-2470141.6
United Kingdom
England and Wales1994(1)16-24144216.50.54.01.62.0
England and Wales1996(2)16-24147516.10.65.72.91.1
England and Wales1998(3)16-24129518.01.05.32.20.4
England and Wales2000(4)16-24151717.41.92.93.20.6
England and Wales2001-02(5)16-24405717.12.22.03.60.3
England and Wales2002-03(6)16-24429216.62.31.72.70.3
England and Wales2003-04(7)16-24542915.82.81.62.60.4
England and Wales2004-05(8)16-24628714.12.21.31.90.2
England and Wales2005-06(9)16-24589213.03.01.62.00.2
Northern Ireland2002-03(10)15-247.90.20.42.00.0
Scotland2003(11)16-2461914.31.30.72.50.0
Scotland2004(12)16-243307.80.51.01.40.3
United Kingdom2004(13)15.22.51.52.50.4
Norway
National1999(1)15-24
National2004(2)15-246455.90.40.20.30.0

Notes:

 (1) Cocaine any form.   

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy, for Denmark National 1994: hard drugs.   

 (3) For Spain: ecstasy and other designer drugs.   

 (4) Results of this survey should be viewed with caution due to important discrepancies with previous surveys and school surveys results.   

 This table aims to present an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as reference point for the 1993 survey.    

 In surveys with small sample sizes results should be interpreted with caution.   

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.   

 For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions.   

 For methods of each survey presented in this table, see Table GPS-1 part (ii).    

 See also 'General notes for interpreting data' on the Explanatory notes and help page.   

Sources:

 See Table GPS-0.   

Page last updated: Wednesday, 07 November 2007